HomeAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$33.65
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$33.65
Sarado: Hun 26, 4:01:22 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$32.71
Sakop ng araw
$32.59 - $33.70
Sakop ng taon
$23.42 - $62.58
Market cap
1.95B USD
Average na Volume
601.42K
P/E ratio
2.98
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 8.73M | 6.56% |
Gastos sa pagpapatakbo | 41.53M | 33.90% |
Net na kita | -89.29M | -9.49% |
Net profit margin | -1.02K | -2.75% |
Kita sa bawat share | -1.55 | -6.90% |
EBITDA | -105.35M | -16.12% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 893.38M | 49.40% |
Kabuuang asset | 1.56B | 83.06% |
Kabuuang sagutin | 88.99M | -15.88% |
Kabuuang equity | 1.47B | — |
Natitirang share | 57.92M | — |
Presyo para makapag-book | 1.29 | — |
Return on assets | -16.56% | — |
Return on capital | -17.10% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -89.29M | -9.49% |
Cash mula sa mga operasyon | -111.49M | -11.64% |
Cash mula sa pag-invest | 112.59M | -9.61% |
Cash mula sa financing | 1.62M | -72.39% |
Net change in cash | 2.72M | -91.11% |
Malayang cash flow | -87.33M | -20.46% |
Tungkol
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Itinatag
2008
Website
Mga Empleyado
487
